Tag Archives: biotech

Targeted Medical Pharma Announces Changes in Management and Board of Directors

New Management Structure Positions Company for Growth and Profitability Los Angeles, CA, January 29, 2015 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced several major changes that streamline operations and signify a commitment to revenue growth, cost containment and profitability. The Company has appointed Kim Giffoni, a co-founder and former Vice President of Foreign Sales at Targeted Medical Pharma, as the Chief Executive Officer. Dr. David Silver, former Chief Operating Officer and President at the Company, has been appointed Chief Medical Officer, and Marcus Continue reading →

Targeted Medical Pharma Announces Completion of Sales Agreement with Pacific Medical, Inc

Agreement Provides the Company with the Ability to Rapidly Expand Sales and Education Programs Los Angeles, CA, January 10, 2014 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), reported on the completion of an independent sales agreement with Pacific Medical, Inc., a distributor of durable medical equipment in the United States who specializes in orthopedic, rehabilitation, surgery and sports medicine. The non-exclusive agreement will allow Targeted Medical Pharma to expand medical food sales and education programs to licensed healthcare professionals in Northern California and Northern Nevada Continue reading →

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase

Targeted Medical Pharma to Present at the Demy-Colton 2014 BIOTECH Showcase Los Angeles, January 9, 2014 — Targeted Medical Pharma, announced that members of its executive team are scheduled to present the latest information regarding medical foods at the sixth annual Biotech Showcase™ on January 14, 2014 at 4:00 p.m. PST, at the Parc 55 Wyndham Hotel in San Francisco, CA. Management also will conduct one-on-one meetings with investors from January 13-15, 2014. Biotech Showcase is an investor and partnering conference devoted to providing private Continue reading →

Targeted Medical Pharma to Present at 2013 Rodman & Renshaw Annual Global Investment Conference

Los Angeles, CA, September 5th, 2013 — Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced that the company’s CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Rodman & Renshaw Annual Global Investor Conference being held at the Millennium Broadway Hotel, New York, on Monday, September 9, 2013 at 11:40 a.m. EST. The conference will feature more than 200 public & private companies from around the world and is expected to present to an audience of over 1,500 attendees. The Continue reading →

Targeted Medical Pharma to Present at Marcum Microcap Conference

LOS ANGELES, May 22, 2013 — Targeted Medical Pharma, Inc. (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Chief Executive and Chief Science Officer, Dr. William Shell, will be presenting at the Marcum MicroCap Conference.   The conference will be held on Thursday, May 30, 2013 at the Grand Hyatt Hotel, located at 109 East  42nd Street in New York City.  Dr. Shell’s presentation will take place at 4:30 p.m. EST in the Estate Continue reading →

Targeted Medical Pharma to Present at OneMedForum Healthcare Conference

Los Angeles, December 18, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians and pharmacies , today announced that members of its executive team are scheduled to present at the sixth annual OneMedForum on January 8, 2013 at 3:40 p.m. PST, being held at the Sir Francis Drake Hotel in San Francisco. Management also will conduct one-on-one meetings with investors from January 7-9, 2013, concurrent with the 31st Annual J.P. Morgan Continue reading →